UBS Mid Caps USA Equity Fund is an actively managed equity fund with a history going back to 1995. The management company, UBS Asset Management, is the asset management division of UBS Group AG, the listed Swiss banking group headquartered in Zürich.
Investment philosophy
The fund invests predominantly in companies with a market capitalisation below USD 10 billion. In selecting stocks, the managers emphasise companies' flexibility and ability to innovate. The managers sit in the team for US large and mid-cap growth equities.
The managers
Peter J. Bye, John Strommen and Katie Thompson co-manage the fund. Bye has managed the fund since 2016 and is based in New York. He joined UBS Asset Management in 2010 and has industry experience going back to 1992. He has particular responsibility for research and stock selection in health care, after about twelve years as a health care equity analyst at Cowen, Citigroup, Wachovia and Jefferies. He has also worked as a quantitative analyst at Putnam Investments and holds a degree from Harvard University. Strommen is based in New York and has been on the fund since 2022. Thompson is based in London and has managed the fund since 2024. Bye and Thompson also manage the UBS USA Growth Equity Fund.
The portfolio
Some of the core positions have held from month to month, including Cencora and DexCom.
FundTelligence description · 18/10/2026
Comparison basis: Ranked among 11 of 17 funds · 6 left out (4 share class outside the rule, 1 history too short, 1 return without a stated date) · returns as of 12 Nov 2026–16 Nov 2026
US Small/Mid Cap Equities · 17 funds in the peer group. The number ranked and the date are stated per period. 9 of them converted to NOK.
3 of 11 funds ranked on a calculated return
#10/ 11Year to date
-3.50% NOK
as of 13 Nov 2026 · Converted from USD to NOK
About the figures
6 of 17 funds in the group hold no figure for the date and are not counted. 5 funds with older figures: up to 5 business days.
#11/ 121 year
-2.94% NOK
as of 13 Nov 2026 · Converted from USD to NOK
About the figures
5 of 17 funds in the group hold no figure for the date and are not counted. 5 funds with older figures: up to 5 business days.
#6/ 103 years (ann.)
+5.78% NOK
as of 13 Nov 2026 · Converted from USD to NOK
About the figures
7 of 17 funds in the group hold no figure for the date and are not counted. 4 funds with older figures: up to 5 business days.
#6/ 105 years (ann.)
+2.68% NOK
as of 13 Nov 2026 · Converted from USD to NOK
About the figures
7 of 17 funds in the group hold no figure for the date and are not counted. 4 funds with older figures: up to 5 business days.
Comparison basis
Year to date
Comparison basis: Ranked among 11 of 17 funds · 6 left out (4 share class outside the rule, 1 history too short, 1 return without a stated date) · returns as of 12 Nov 2026–16 Nov 2026
1 year
Comparison basis: Ranked among 12 of 17 funds · 5 left out (1 missing return, 2 return as of an earlier date, 2 return without a stated date) · returns as of 12 Nov 2026–16 Nov 2026
3 years (ann.)
Comparison basis: Ranked among 10 of 17 funds · 7 left out (2 share class outside the rule, 1 missing return, 2 return as of an earlier date, 2 return without a stated date) · returns as of 12 Nov 2026–16 Nov 2026
5 years (ann.)
Comparison basis: Ranked among 10 of 17 funds · 7 left out (3 share class outside the rule, 1 missing return, 1 return as of an earlier date, 2 return without a stated date) · returns as of 12 Nov 2026–16 Nov 2026
The positions describe historical return and are not an assessment of the fund, nor investment advice. Past performance is no guarantee of future returns. A position applies only within its own peer group and cannot be compared with positions in other peer groups.
Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.